Hendershot Investments Inc. Sells 94 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hendershot Investments Inc. lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 571 shares of the medical equipment provider’s stock after selling 94 shares during the period. Hendershot Investments Inc.’s holdings in Intuitive Surgical were worth $298,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Massachusetts Financial Services Co. MA purchased a new stake in Intuitive Surgical during the 3rd quarter valued at $558,807,000. International Assets Investment Management LLC increased its position in Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. FMR LLC boosted its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB grew its stake in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares during the period. Finally, Strategic Financial Concepts LLC increased its position in shares of Intuitive Surgical by 50,740.8% during the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock valued at $163,202,000 after purchasing an additional 312,056 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.9 %

Shares of Intuitive Surgical stock opened at $582.98 on Friday. The firm has a market cap of $207.65 billion, a PE ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39. The stock has a 50 day moving average of $554.85 and a 200 day moving average of $513.96. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Insider Activity

In related news, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,940 shares of company stock worth $3,333,485. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts recently issued reports on ISRG shares. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Bernstein Bank upped their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Barclays boosted their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Royal Bank of Canada raised their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.